Centralization of care for patients with advanced-stage ovarian cancer: A cost-effectiveness analysis

被引：0
|
作者：
Bristow, Robert E. [1 ]
Santillan, Antonio [1 ]
Diaz-Montes, Teresa P. [1 ]
Gardner, Ginger J. [1 ]
Giuntoli, Robert L., II [1 ]
Meisner, Benjamin C. [1 ]
Frick, Kevin D. [1 ]
Armstrong, Deborah K. [1 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
GYNECOLOGIC ONCOLOGY | 2007年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] Centralization of care for patients with advanced-stage ovarian cancer - A cost-effectiveness analysis
    Bristow, Robert E.
    Santillan, Antonio
    Diaz-Montes, Teresa R.
    Gardner, Ginger I.
    Giuntoli, Robert L., II
    Meisner, Benjamin C.
    Frick, Kevin D.
    Armstrong, Deborah K.
    CANCER, 2007, 109 (08) : 1513 - 1522
  • [2] Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis
    Greving, Jacoba P.
    Vernooji, Flora
    Heintz, A. Peter M.
    van der Graaf, Yolanda
    Buskens, Erik
    GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 68 - 74
  • [3] A cost-effectiveness analysis of adjuvant treatment strategies for advanced-stage endometrial cancer
    Chura, J.
    Rocconi, R.
    Axtell, A.
    Straughn, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S78 - S78
  • [4] Cost-Effectiveness of Early-Initiated Treatment for Advanced-Stage Epithelial Ovarian Cancer Patients A Modeling Study
    Hoyer, Tom
    Bekkers, Ruud
    Gooszen, Hein
    Massuger, Leon
    Rovers, Maroeska
    Grutters, Janneke P. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (01) : 75 - 84
  • [5] Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
    Shuling Chen
    Zhenwei Peng
    Mengchao Wei
    Weifeng Liu
    Zihao Dai
    Haibo Wang
    Jie Mei
    Mingfong Cheong
    Hanmei Zhang
    Ming Kuang
    BMC Cancer, 18
  • [6] Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
    Chen, Shuling
    Peng, Zhenwei
    Wei, Mengchao
    Liu, Weifeng
    Dai, Zihao
    Wang, Haibo
    Mei, Jie
    Cheong, Mingfong
    Zhang, Hanmei
    Kuang, Ming
    BMC CANCER, 2018, 18
  • [7] Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
    Jang, Jaehyeok
    Kim, Yoonjung
    Kim, Jae-Hoon
    Cho, Sun-Mi
    Lee, Kyung-A
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (01) : 73 - 81
  • [8] BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN'S LYMPHOMA: A COST-EFFECTIVENESS ANALYSIS
    Raymakers, A.
    Costa, S.
    Peacock, S. J.
    Regier, D.
    VALUE IN HEALTH, 2018, 21 : S44 - S44
  • [9] Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma
    Vijenthira, Abi
    Chan, Kelvin
    Cheung, Matthew
    Prica, Anca
    BLOOD, 2018, 132
  • [10] Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy
    Carla Rognoni
    Domenica Lorusso
    Francesco Costa
    Patrizio Armeni
    Advances in Therapy, 2024, 41 : 1385 - 1400
12345